CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

Telitacicept

Recombinant proteinexperimental

Clinical trial activity

49 trials · 37 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
32
Phase 3
15
Phase 4
9

Earliest trial started Oct 1, 2015 (NCT02882087)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 3 Sponsor(trial)

  3. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • rc18

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07298928N/AJan 15, 2026Zhejiang University
NCT07249632Phase 3Nov 30, 2025Fudan University, Peking University, RemeGen
NCT07052981Phase 3Aug 1, 2025Nanjing Medical University
NCT07077486Phase 4Jul 25, 2025Huazhong University of Science and Technology, Wuhan Central Hospital, Wuhan University
NCT07111338Phase 2Jul 12, 2025Peking University
NCT07008196Phase 4Jun 10, 2025Chinese Academy of Medical Sciences, Chinese SLE Treatment And Research Group
NCT06827587N/AFeb 28, 2025Ningbo Medical Center Lihuili Eastern Hospital, Wenzhou Medical University, Zhejiang University
NCT06723548Phase 4Dec 31, 2024Wenzhou Medical University
NCT06654596N/ANov 30, 2024Fudan University, Jiao Tong University, Second Military Medical University, Shanghai Longhua Hospital, Sichuan University, Wannan Medical College, Wuhan University, Yijishan Hospital of Wannan Medical College
NCT06614985Phase 2Oct 20, 2024Wuhan University
NCT06677801Phase 4Oct 11, 2024Zhejiang University
NCT06656962Phase 1/Phase 2 (Phase 2)Oct 10, 2024Wuhan University
NCT06456567Phase 3Sep 30, 2024RemeGen
NCT06549959Phase 1Aug 5, 2024RemeGen
NCT06510283Phase 2Aug 1, 2024Capital Medical University
NCT07098897Phase 3Aug 1, 2024Xuzhou Medical University
NCT06456580Phase 3Jul 17, 2024RemeGen
NCT06394063N/AJun 28, 2024Jiao Tong University
NCT06546540Phase 4Jun 8, 2024Peking University
NCT06375005Phase 2Jun 1, 2024Zhejiang University
Showing 20 of 49 trials
Page 1 / 3

Organizations

Research & Development (37)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
RemeGenFor profit232242015
Peking UniversityAcademic/Hospital9432017
Chinese Academy of Medical SciencesAcademic/Hospital8242019
Zhejiang UniversityAcademic/Hospital6542023
Jiao Tong UniversityAcademic/Hospital5322015
Wuhan UniversityAcademic/Hospital4232024
Chinese SLE Treatment And Research GroupAcademic/Hospital3312023
Central South UniversityAcademic/Hospital2122022
Fudan UniversityAcademic/Hospital2022024
Huazhong University of Science and TechnologyAcademic/Hospital2122023
Sichuan UniversityAcademic/Hospital2022023
Tsinghua UniversityAcademic/Hospital2022015
Wenzhou Medical UniversityAcademic/Hospital2222024
Zhengzhou UniversityAcademic/Hospital2112023
Anhui Medical UniversityAcademic/Hospital1012023
Bengbu Medical CollegeAcademic/Hospital1012019
Capital Medical UniversityAcademic/Hospital1112024
Changhai HospitalAcademic/Hospital1012023
China Academy of Chinese Medical SciencesAcademic/Hospital1012023
China Medical UniversityAcademic/Hospital1012023
37 organizations
Page 1 / 2